News &amp; Updates

The combination of aspirin and warfarin therapy appears to increase the risk of bleeding, with little benefit in reducing stroke or cardiovascular events compared with warfarin alone in patients with atrial fibrillation (AF), reveals a study.

Warfarin plus aspirin tied to higher bleeding risk than monotherapy in AF patients

18 Oct 2021

Cold atmospheric plasma device eases severity of atopic dermatitis

Use of the cold atmospheric plasma (CAP) device, which generates free radicals through the ionization of air at room temperature, results in significantly improved mild and moderate atopic dermatitis (AD) with no serious safety concerns, a study has shown.

Cold atmospheric plasma device eases severity of atopic dermatitis

18 Oct 2021

Fitness trackers fall short of accurate sleep, heart rate monitoring in naturalistic scenarios

While wearable fitness trackers have the potential to provide accurate sleep and heart rate (HR) estimates in shift workers under naturalistic conditions, crucial limitations of the technology become apparent when compared against the gold standard of polysomnography (PSG), even after careful data treatment, according to a recent study

Fitness trackers fall short of accurate sleep, heart rate monitoring in naturalistic scenarios

Antiplatelet plus anticoagulant therapy linked to better outcomes in COVID-19

Hospitalized patients with COVID-19 who receive antiplatelet and anticoagulant drugs concurrently may fare better than those given only therapeutic anticoagulation, according to a study.

Antiplatelet plus anticoagulant therapy linked to better outcomes in COVID-19

18 Oct 2021

Triple combo improves outcomes in cystic fibrosis patients with certain genotype

Treatment with the combination of elexacaftor/tezacaftor/ivacaftor appears to be safe and effective in patients with cystic fibrosis who harbour the Phe508del and minimal function mutations, a study has shown.

Triple combo improves outcomes in cystic fibrosis patients with certain genotype

Tapinarof a new kid on the block for plaque psoriasis

Treatment with the nonsteroidal topical cream tapinarof 1% for up to 52 weeks helps control plaque psoriasis in the phase III PSOARING 3 trial.

Tapinarof a new kid on the block for plaque psoriasis

CDK4/6 inhibitors + fulvestrant improve OS in HR-positive, HER2-negative advanced breast cancer

The addition of a cyclin-dependent kinase 4/6 (CDK 4/6) inhibitor to fulvestrant provides a consistent benefit in overall survival (OS) in patients with hormone receptor (HR)–positive, HER2-negative, advanced or metastatic breast cancer in first-, second- and later-line settings and in most clinicopathological subgroups of interest, results of a US FDA pooled analysis of have shown.

CDK4/6 inhibitors + fulvestrant improve OS in HR-positive, HER2-negative advanced breast cancer

18 Oct 2021

New diagnostic model detects obstructive sleep apnoea in primary care

A combination of clinical judgment and portable monitor test outcomes can help diagnose obstructive sleep apnoea (OSA) in the primary care setting, a recent study has shown.

New diagnostic model detects obstructive sleep apnoea in primary care

HPV infection spoils semen quality

HPV DNA appears to be prevalent in the sperm of men with infertility, and its presence is linked to reduced sperm motility and concentration, as reported in a study.

HPV infection spoils semen quality

High cardiorespiratory fitness offsets effect of low socioeconomic status on COPD risk

Low socioeconomic status is linked to increased risk of chronic obstructive pulmonary disorder (COPD) among middle-aged men, but high cardiorespiratory fitness can even out this risk increase, a study has shown.

High cardiorespiratory fitness offsets effect of low socioeconomic status on COPD risk